This is my last newsletter as President of The Aesthetic Foundation, and it has been a busy and productive year. Our core mission is to support research that is relevant to practicing plastic surgeons and improve the safety and effectiveness of the procedures that we offer to our patients.
Blog
Spring is just around the corner, and The Aesthetic Society is already experiencing renewed energy and new growth. I wanted to answer some questions about what’s next.
It is just about two months from The Aesthetic MEET, and we have no lack of education, networking, and fun for you to take part in while you are in Boston. There are many opportunities to engage with and support The Aesthetic Foundation during The MEET, and I look forward to connecting and sharing all that has been accomplished with you.
I can’t believe we are already halfway into January, and I have been President of the Aesthetic Foundation for almost 9 months, the time has flown by.
In this study, 11 patients were injected with Volbella XC into the tear trough region and subsequently underwent undereye volumetric measurements over a 90-day period.
For this post hoc analysis, the authors extracted and analyzed data from the BLESS III study to determine whether there were variances in the effectiveness and safety of letibotulinumtoxinA for treating vertical glabellar lines between the broader female study population and a group of female participants aged 35 to 50.
Needle-free jet injector (NFJI) devices offer an alternative to traditional needle–syringe injection for administration of medications, vaccines, and other fluids.
Biostimulators and energy-based devices are increasingly used in combination to address visible signs of aging.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”
The recent Facial and Rhinoplasty Symposium was a tremendous success – and a great example of how The Society is evolving to meet the needs of our members and the demands of a fast-changing industry.